3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
96
Stomach Neoplasms
53
Rectal Neoplasms
49
Pancreatic Neoplasms
42
Colonic Neoplasms
34
Esophageal Neoplasms
30
Neoplasm Metastasis
28
Neoplasms
23
Adenocarcinoma Of Esophagus
19
Adenocarcinoma
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
7
Lymphoma, Large B-Cell, Diffuse
7
Gallbladder Neoplasms
7
Biliary Tract Neoplasms
7
Esophageal Squamous Cell Carcinoma
6
Carcinoma, Non-Small-Cell Lung
6
Ovarian Neoplasms
5
Liver Neoplasms
5
Head and Neck Neoplasms
5
Cholangiocarcinoma
5
Recurrence
4
Lymphoma, Non-Hodgkin
4
Gastrointestinal Neoplasms
4
Carcinoma, Hepatocellular
4
Breast Neoplasms
4
Bile Duct Neoplasms
4
Peritoneal Neoplasms
3
Pancreatic Adenocarcinoma
3
Leukemia
3
Fallopian Tube Neoplasms
3
Interventions
Pemetrexed
15
Cisplatin
13
pembrolizumab
6
Platinum
4
1,2-diaminocyclohexaneplatinum II citrate
4
cediranib
3
Radiotherapy
3
Gemcitabine
3
Carboplatin
3
amatuximab
2
Radiotherapy, Intensity-Modulated
2
Radiation
2
Everolimus
2
Drug Therapy
2
Cyclophosphamide
2
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
tremelimumab
1
sodium thiosulfate
1
sargramostim
1
nintedanib
1
napabucasin
1
methoxyamine
1
liposomal doxorubicin
1
incomplete Freund's adjuvant
1
fresolimumab
1
durvalumab
1
defactinib
1
cixutumumab
1
bintrafusp alfa protein, human
1
bemcentinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Mesothelioma, Malignant
×
Oxaliplatin
×
Clear all
No trials found.